Listed on GrantGunner. Last checked 13 Nov 2026.
About this grant
The application round for the special acceleration program is aimed at high-potential companies operating at the intersection of health technology, techbio, and pharmaceutical research and development. This three-month hybrid program is designed to help startup founders refine their value propositions and build essential partnerships in the global pharmaceutical industry, offering an equity- and tuition-free curriculum and the opportunity to qualify for up to 50,000 Swiss francs in non-dilutive funding.
Who can apply
Early-stage startups operating at the intersection of health technology, techbio, and pharmaceutical R&D.